Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th:
Bicycle Therapeutics plc (BCYC - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
Bicycle Therapeutics PLC Sponsored ADR Price and Consensus
Bicycle Therapeutics' shares gained 0.9% over the last one month compared to S&P 500’s fall of 19.8%. The company possesses a Momentum Score of B.
Bicycle Therapeutics PLC Sponsored ADR Price
Co-Diagnostics, Inc. (CODX - Free Report) : This molecular diagnostics company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.
Co-Diagnostics, Inc. Price and Consensus
Co-Diagnostics’ shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.
Co-Diagnostics, Inc. Price
Zeons Corporation (ZEON - Free Report) : This producer of bio fuels, including fuels for diesel, gasoline, and natural gas engines from agricultural feed stocks, such as soybeans and corn has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Zeons Corporation Price and Consensus
Zeons’ shares gained 95% over the last one month. The company possesses a Momentum Score of B.
Zeons Corporation Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th:
Bicycle Therapeutics plc (BCYC - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.9% over the last 60 days.
Bicycle Therapeutics PLC Sponsored ADR Price and Consensus
Bicycle Therapeutics' shares gained 0.9% over the last one month compared to S&P 500’s fall of 19.8%. The company possesses a Momentum Score of B.
Bicycle Therapeutics PLC Sponsored ADR Price
Co-Diagnostics, Inc. (CODX - Free Report) : This molecular diagnostics company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.
Co-Diagnostics, Inc. Price and Consensus
Co-Diagnostics’ shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.
Co-Diagnostics, Inc. Price
Zeons Corporation (ZEON - Free Report) : This producer of bio fuels, including fuels for diesel, gasoline, and natural gas engines from agricultural feed stocks, such as soybeans and corn has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Zeons Corporation Price and Consensus
Zeons’ shares gained 95% over the last one month. The company possesses a Momentum Score of B.
Zeons Corporation Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ZEON - FREE
Get the latest research report on CODX - FREE
Get the latest research report on BCYC - FREE